x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAB-0011066
| Product Information | |
|---|---|
| Clonality | Polyclonal |
| Isotype | IgG |
| Host Species | Rabbit |
| Reactivity | Human, Mouse, Chimpanzee, Rhesus monkey, Gorilla |
| Applications | IHC-P, WB, IP |
| Product Description | Rabbit polyclonal antibody to KAT13C / NCOA2. |
| Format | Liquid |
| Purity | Affinity purity |
| Target Information | |
|---|---|
| Target Name | NCOA2 |
| UniProt No. | Q15596 |
| Gene ID | 10499 |
| Gene Description | Transcriptional coactivator for steroid receptors and nuclear receptors. Coactivator of the steroid binding domain but not of the modulating N-terminal domain. Required with NCOA1 to control energy balance between white and brown adipose tissues. |
| Shipping & Storage | |
|---|---|
| Shipping | Shipped at 4 °C. |
| Storage Instructions | Upon delivery aliquot and store at -20 °C. Avoid freeze / thaw cycles. |
| Storage Buffer | pH: 7; Preservative: 0.1% Sodium azide; Constituents: 0.021% PBS, 1.764% Sodium citrate, 1.815% Tris |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
